| 000 | 01860 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516180338.0 | ||
| 264 | 0 | _c20140611 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1424-3997 | ||
| 024 | 7 |
_a10.4414/smw.2013.13896 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBally, Klaus | |
| 245 | 0 | 0 |
_aDiscontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients. _h[electronic resource] |
| 260 |
_bSwiss medical weekly _c2013 |
||
| 300 |
_aw13896 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGeneral Practice _xmethods |
| 650 | 0 | 4 |
_aGuideline Adherence _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aSecondary Prevention _xmethods |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aBuechel, Ronny R | |
| 700 | 1 | _aBuser, Peter | |
| 700 | 1 | _aTschudia, Peter | |
| 700 | 1 | _aMartinaa, Benedict | |
| 700 | 1 | _aZeller, Andreas | |
| 773 | 0 |
_tSwiss medical weekly _gvol. 143 _gp. w13896 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4414/smw.2013.13896 _zAvailable from publisher's website |
| 999 |
_c23232802 _d23232802 |
||